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ABSTRACT
The most important diseases of cultured penaeid shrimp, in terms of economic impact, in 
Asia, the Indo-Pacific, and the Americas, have infectious etiologies. Although diseases with 
bacterial, fungal, and parasitic etiologies are also important, certain virus-caused diseases stand 
out as the most significant. The pandemics due to the penaeid viruses WSSV, TSV, YHV, and 
IHHNV have collectively cost the penaeid shrimp industry billions of dollars in lost crops, jobs, 
and export revenue. Although not as sudden nor as catastrophic in their onset and course, certain 
bacterial, fungal, and parasitic diseases of shrimp have also been responsible for very significant 
production losses, and the relative importance of many of these diseases should not be discounted. 
The social and economic impacts of the pandemics caused by WSSV and TSV have been 
especially profound in the Americas, and in the wake of these viral pandemics the shrimp culture 
industry has sought ways to restore the industry’s levels of production to the “pre-virus” years. 
Central to improving disease) prevention and management strategies is the incorporation of the 
concepts of biosecurity into shrimp farm design and operational strategies. Disease management in 
shrimp aquaculture is an important component to biosecurity of farms and to the sustainability of 
individual farms, shrimp farming countries, or entire geographic regions. The first step in disease 
management requires the availability of accurate and reliable diagnostic methods and knowledge of 
the biology of the diseases of concern. The recognition of the need for biosecurity and disease 
management in the Americas is reflected in the recent proliferation of shrimp disease diagnostic 
laboratories in the Americas. Where there were only a handful of shrimp disease diagnostic laboratories 
a decade ago, there are 40 or more such laboratories serving the industry today.
Diagnostic methods may be applied to determining the cause of disease(s) that are 
adversely affecting the culture performance or survival of farmed shrimp stocks or they may be 
used for surveillance purposes to screen for the presence of specific pathogens in otherwise 
healthy shrimp for the purpose of disease control. As diagnostic methods have improved and 
become more widely available, the interest in culturing specific pathogen-free (SPF) shrimp stocks 
in biosecure facilities has increased markedly in many regions in the Americas. The methods being 
used in shrimp disease diagnostic laboratories in the Americas were recently surveyed. Of the 40 
laboratories contacted, 27 responded to the survey. Approximately 75% of the labs responding to 
the survey provide diagnostic services using both molecular (PCR, RT-PCR and gene probes) and 
classical (routine histology and microbiology) methods, while nearly all (93%) of the diagnostic 
labs offer diagnostic testing and screening services based on molecular methods (i.e. assays with 
gene probes and PCR/RT-PCR).
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INTRODUCTION
The global penaeid shrimp farming industry is nearly 30 years old and it produced about 
865,000 metric tons of whole shrimp in 2000 from its farms (Rosenberry, 2001). The importance of 
the industry to the global economy is reflected in these production numbers and by the millions of 
persons employed directly or indirectly by the industry. That farmed shrimp are among the most 
important foreign exchange earners for many tropical and subtropical coastal nations further 
documents the economic and social importance of the industry. Certain diseases have had a 
profound effect on penaeid shrimp aquaculture. Rosenberry (2001) estimated that disease due to 
the white spot syndrome virus (WSSV) “robbed the industry” of approximately 200,000 metric tons 
of production in 2000 worth more than $1 billion. WSSV and other infectious agents have been and 
continue to be significant impediments to the development and sustainability of the industry. 
Disease in shrimp farming may be defined as any adverse condition due to biotic (living 
or infectious) agents or abiotic (non-living) agents that adversely affects culture performance 
(Lightner, 1996a). Biotic diseases of shrimp are those that have living agents as the cause, while 
abiotic diseases may be caused by environmental or physical extremes (temperature, hypoxic 
conditions, nitrogen supersaturation, extremes of pH, etc.), chemical toxicants, pesticides, nutritional 
deficiencies or imbalances, improper handling, etc. Most biotic diseases have infectious etiologies, 
and the list of biotic diseases affecting shrimp is not too different from the list of diseases that 
affect other animals. Many of the major causes of any kind of disease in vertebrate animals are 
represented in penaeid shrimp. Shrimp have infectious diseases caused by viruses, rickettsia, true 
bacteria, protozoan and helminth parasites, etc. They have benign and neoplastic tumors and they 
develop nutritional diseases when fed inadequate diets (Lightner, 1988, 1993a, 1993b, 1996a). 
The terms “disease agent” (= etiological agent or pathogen) and “disease” may be defined 
differently by biomedical and aquaculture pathology professionals. There is an ongoing debate as 
to whether non-clinical infections (i.e. the presence and reproduction of a pathogen in a host) 
constitute a positive diagnosis of disease. The terms as used in this review are according to the 
definitions given in the Aquatic Animal Health Code published by the International Office of 
Epizootics (OIE, 2000a), the administrative arm of the World Animal Health Organization. For the 
sake of clarity, these OIE definitions are given here: 
Disease - means clinical or non-clinical infections with one or more etiological agents of the 
diseases listed in the OIE Code.
Disease agent - means an organism that causes or contributes to the development of a disease 
listed in the OIE Code.
With these definitions it is apparent that OIE defines disease to include non-clinical 
infections by particular pathogens, as well as clinical infections which may be accompanied by 
high mortality rates. Therefore, the detection of particular pathogen in a diagnostic assay is a 
positive case of the disease caused by that disease agent.
The most important diseases of cultured penaeid shrimp, in terms of economic impact, in 
Asia, the Indo-Pacific, and the Americas have infectious agents as their cause (Tables 1 and 2). 
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Table 1. Major diseases of Indo Pacific and east Asian penaeid shrimp 
Viral Diseases Bacterial and Fungal Diseases Other Diseases
White Spot Syndrome Virus







- septic HP necrosis
- hatchery vibriosis












Toxic syndromes and 
environmental extremes
Table 2. Major diseases of the American penaeid shrimp 
Viral Diseases Bacterial and Fungal Diseases Other Diseases
White Spot Syndrome Virus Vibriosis: Epicommensals and parasites:
Taura Syndrome Virus - ‘Sindrome Gaviota’ - Leucothrix mucor
IHHNV - hatchery vibriosis - peritrich protozoans
BP group - luminescent vibrio - gregarines
HPV group - shell disease - microsporidians
REO III? Other bacteria:
LOW? - NHP bacterium
RPS?
Yellow Head Virus? Fungal: Nutritional imbalances
- Larval Mycosis Toxic syndromes and
- Fusariosis environmental extremes
Zoea II syndrome
Among the infectious diseases of cultured shrimp, certain virus-caused diseases stand out as the 
most significant. Some of the most important diseases (and their etiological agents) were once 
limited in distribution to either the Western or Eastern Hemisphere (Fulks and Main, 1992; Lightner, 
1996a). However, the international movement of live (for aquaculture) and dead (commodity 
shrimp for reprocessing and commerce) has led to the transfer and establishment of certain 
pathogens from one hemisphere to the other (Lightner 1996b; Lightner et al., 1995; Durand et al., 
2000; AQUIS, 2000). WSSV was moved from Asia to the Americas by this route and TSV was 
moved in the opposite direction (Nunan et al., 1998a; Tu et al., 1999; Durand et al., 2000). Perhaps 
these transfers and introductions could have been prevented if the industries and governments of 
the exporting and importing countries had known of the risks posed by their actions and if the 
appropriate disease diagnostic and pathogen detection methods had been readily available when 
the most damaging transfers were being made. Many of the most significant shrimp pathogens 
were moved from the regions where they initially appeared to new regions even before the “new” 
pathogen had been recognized, named, proven to cause the disease, and before reliable diagnostic 
methods were developed. The pandemics due to the penaeid viruses WSSV and TSV, and to a 
lesser extent to IHHNV and YHV, cost the penaeid shrimp industry billions of dollars in lost crops, 
jobs, and export revenue well before their etiology was understood (Table 3). The social and 
9
economic impacts of the pandemics caused by these pathogens in countries in which shrimp 
fanning constitutes a significant industry have been profound. In the wake of the viral pandemics 
the shrimp culture industry has sought ways to restore the industry’s levels of production to the 
“pre-virus” years. The application of biosecurity to shrimp farming, coupled with improved disease 
diagnostic methods and support, is central to those efforts.
Table 3. Estimated economic losses since the emergence or introduction of diseases due to WSSV, TSV and 
IHHNV in the penaeid shrimp aquaculture industry of the America:
Virus Year of emergence to 2001 Product loss (dollars)
WSSV-Americas 1999 1-2 billion
TSV 1991-92 1-2 billion
IHHNV* 1981 0.5-1.0 billion
* Includes Gulf of California fishery losses for 1989-1994.
This paper reviews the current status of diagnostic methods and infrastructure in the 
Americas and its application with certain of the concepts and principles of biosecurity to shrimp 
disease management strategies in the Americas. Shrimp taxonomy used in this review is according 
to Holthuis (1950).
CURRENT DIAGNOSTIC METHODS
Modem penaeid shrimp diagnostic and research laboratories are based on traditional 
methods of disease diagnosis and pathogen detection that have been adapted from methods used 
in fish, veterinary and human diagnostic laboratories. Methods for the detection of pathogens and 
the diagnosis of diseases that are currently in use by shrimp pathologists and by diagnostic labs 
have been reviewed many times in the past decade (Baticados, 1988; Baticados et al., 1990; Brock, 
1991, 1992; Brock and Lightner, 1990; Brock and LeaMaster, 1992; Brock and Main, 1994; Flegel et 
al. 1992; Fulks and Main, 1992; Johnson, 1990, 1995; Lightner, 1988, 1993a, 1993b, 1996a, 1999a; 
Lightner and Redman, 1991, 1992, 1998; Lightner et al., 1992a, 1992b, 1994; Limsuwan, 1993;Liu, 
1989; OIE, 2000a, 2000b). In penaeid shrimp pathology, diagnosticians rely heavily on case history, 
gross signs and behavior, morphological pathology (direct bright-field or phase contrast light 
microscopy and electron microscopy) and classical microbiology (bacteriology and mycology) 
(Table 4). Among the most important of these are gross and clinical signs, with the most commonly 
applied laboratory tests being direct examination and microscopy using the light microscope, 
classical microbiology with isolation and culture of the agent, and routine histology and 
histochemistry (Bell and Lightner, 1988; Lightner, 1996a). Virtually every functional shrimp 
pathology/diagnostic laboratory today is equipped to do direct light microscopic methods and 
routine procedures in histology and bacteriology. Paradoxically, important techniques involving 
tissue and cell culture, hematology and clinical chemistry, which are virtual cornerstones of vertebrate 
biomedical research, diagnostics, and pathology, have either not been successfully applied as 
routine diagnostic tools in penaeid shrimp pathology (in the case of tissue culture), or have not
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Table 4. Methods available to diagnosticians for shrimp disease diagnosis and pathogen detection
Method Tests and Data Obtained
History History of disease at facility or in region, facility design, source of seed 
stock (e.g. wild or domestic specific pathogen-free, SPF, or resistant, 
SPR), type of feed used, environmental conditions, etc.
Gross, clinical signs Lesions visible, behavior, abnormal growth, feeding or food conversion 
efficiency, etc.
Direct microscopy Bright-field, phase contrast or dark-field microscopic examination of 
stained or unstained tissue smears, whole-mounts, wet-mounts, etc., of 
diseased or abnormal specimens
Histopathology Routine histological or histochemical (with special stains) analysis of 
tissue sections
Electron microscopy Ultrastructural examination of tissue sections, negatively stained virus 
preparations, or sample surfaces
Culture & biochemical 
identification
Routine culture and isolation of bacterial isolates on artificial media 
and identification using biochemical reactions on unique substrates.
Enhancement Rearing samples of the appropriate life stages of shrimp under 
controlled, stressful conditions to “enhance” expression of latent or 
low grade infections
Bioassay Exposure of susceptible, indicator shrimp to presumed carriers of a 
pathogenic agent
Antibody-based methods Use of specific antibodies as diagnostic reagents in immunoblot, 
immunohistochemistry, agglutination, IFAT, ELISA, or other tests
Hematology & clinical 
chemistry
Determination of hemocyte differential count, hemolymph clotting 
time, glucose, lactic acid, fatty acids, certain enzymes, etc.
Toxicology/Analysis Detection of toxicants by analysis and verification of toxicity by 
bioassay
DNA probes Detection of unique portions of a pathogen’s nucleic acid using a 
labeled DNA probe
PCR/RT-PCR Amplification of unique sections of a pathogen’s genome to readily 
detectable concentrations using specific primer pairs
Tissue culture In vitro culture of shrimp pathogens in non-shrimp tissue culture 
systems or in primary cell cultures derived from shrimp
provided routinely practical diagnostic data (in the case of hematology and clinical chemistry) 
(Crane and Benzie, 1999). Likewise, the development of antibody-based diagnostic methods for 
penaeid shrimp diseases has not been remarkable until recently (Lightner 1999a), when methods 
based on pathogen detection using monoclonal antibodies were developed (Poulos et al. 1999, 
2001). Even more significant have been the development of molecular methods (using gene probes 
and PCR/RT-PCR), which have been found to provide accurate and standardizable methods for 
disease diagnosis and pathogen detection to the penaeid shrimp culture industries, especially for 
certain penaeid viruses (Chang et al., 1993; Lo et al. 1996, 1997; Lightner, 1996a, 1999a, 1999b; Mari 
et al., 1998; OIE 2000b; Tang and Lightner, 1999) (Tables 5-7).
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Table 5. Diagnostic and pathogen detection methods for the OIE notifiable and listed 
viral diseases of penaeid shrimp (modified from Lightner, 1996a; 
1999a; Lightner and Redman, 1998)
Method* WSSV IHHNV BP MBV BMN SMV YHV-group TSV
Direct BF / LM / PH / DF ++ - +++ +++ ++ - ++ +
Histopathology ++ ++ ++ ++ ++ ++ +++ +++
Bioassay ++ + + - + - + ++
TEM / SEM + + + + + ++ + +
ELISA / IHC with PAbs or MAbs +++ - + - + - +/- ++
DNA Probes DBH / ISH +++ +++ ++ ++ ++ +++ +++ +++
PCR / RT-PCR +++ +++ +++ + - +++ +++ +++
* Definitions for each virus:
– = no known or published application of technique
+ = application of technique known or published, but not commonly practiced or readily
    available
++ = application of technique considered by authors of present paper to provide sufficient
      diagnostic accuracy or pathogen detection sensitivity for most applications
+++ =  technique provides a high degree of sensitivity in pathogen detectionMethods: BF = bright field LM of tissue impression smears, wet-mounts, stained whole mounts; LM = light microscopy; PH = phase microscopy; DF = dark-field microscopy; EM = electron 
microscopy of sections or of purified or semi-purified virus; ELISA = enzyme = linked 
immunosorbent assay; IHC = immunohistochemistry; PAbs = polyclonal antibodies; MAbs 
= monoclonal antibodies; DBH = dot blot hybridization; ISH = in situ hybridization; PCR = 
polymerase chain reaction; RT-PCR = reverse transcriptase PCR
Molecular diagnostic methods have become as important as classical methods (such as 
routine histopathology and microbiology) to the shrimp culture industry in recent years (Lightner, 
1999a; OIE, 2000a, 2000b; Vanpatten and Lightner 2001). Methods employing gene probes PCR/RT- 
PCR have recently developed and applied to the diagnosis of certain infectious diseases of penaeid 
shrimp. Development and application of the first gene probe to the diagnosis of the shrimp virus 
IHHNV was reported only 8 years ago (Lightner et al., 1999b; Mari et al., 1993a). When labeled with 
(what was once traditional) radioactive tags, the use of gene probes was an option for only the best 
equipped diagnostic and research laboratories. However, the application of non-radioactive labeling 
methods has made gene probe technology readily available to shrimp research and diagnostic 
laboratories. The first non-radioactive gene probes for shrimp pathology were developed employing 
the non-radioactive Genius TMI Kit (Boehringer Mannheim, not dated), which contains digoxigenin- 
11-dUTP (DIG) as the DNA label and uses an ELISA-based system for final detection (Lightner et al., 
1994; Mari et al., 1993a). This led to the development of the non-radioactive DIG-labeled gene probes 
for IHHNV and to their commercial application in diagnostic kits marketed under the product name 
‘ShrimProbes™’ by DiagXotics (Wilton, CT, U.S.A.). Now the industry has available from commercial 
sources molecular tests using non-radioactively labeled DNA probes and PCR/RT-PCR methods for 
many of the more significant diseases of penaeids (Table 7).
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Table 6. Summary of methods for surveillance and confirmatory diagnosis of OIE 
Notifiable and Listed penaeid shrimp viral pathogens
AGENT SURVEILLANCE CONFIRMATORY DIAGNOSIS
TSV RT-PCR RT-PCR, DNA probes, AB, histology
WSSV PCR, AB PCR, DNA probes, AB, histology, bioassay
YHV RT-PCR RT-PCR, DNA probes, AB, histology, bioassay
BMN histology Direct microscopy, histology
BP/MBV PCR, direct microscopy, histology Direct microscopy, histology, PCR
IHHNV PCR, DNA probes PCR, DNA probes, histology
SMV none DNA probes, histology, bioassay
Table 7. Commercially available molecular and antibody-based diagnostic products for 
penaeid shrimp pathogens and their applications*
Pathogen DNA-based Tests Antibody-based Tests




WSSV X X X X X
IHHNV X X X
TSV X X X X X
HPV X X X
MBV X X X
BP X X X
YHV X X X
NHP bacterium X X X
* Available from DiagXotics, Inc. Wilton, CT, USA.
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Since the first gene probe to the shrimp parvovirus IHHNV was developed in 1992 (Mari 
et al., 1993a), the technology has been applied to the development of additional gene probes to 
other shrimp viruses, a rickettsia-like bacterium and a microsporidian (Table 7). At the present time, 
DIG-labeled gene probes have been developed and are available for IHHNV, HPV, TSV, BP, MBV, 
WSSV, and YHV (Tables 5 and 8) (Bruce et al., 1993; Durand et al., 1996; Flegel et al., 1996; 
Lightner, 1996a; Lightner et al., 1994; Mari et al., 1993b, 1995; Nunan and Lightner, 1997;Poulos et 
al., 1994; Wang et al., 1995). Using essentially the same technology, additional DIG-labeled gene 
probes have been developed for the causative agent of necrotizing hepatopancreatitis, an 
intracellular, rickettsial-like bacterium (Frelier et al., 1992, 1993, 1994; Krol et al., 1991; Lightner et 
al., 1992c; Lightner, 1996a; Loy and Frelier, 1996; Loy et al., 1996), and for the microsporidian 
Agmasoma sp., which parasitizes P. monodon and P. merguiensis in southeast Asia (Pasharawipas 
and Flegel, 1994; Pasharawipas et al., 1994). Many of these probes are commercially available as 
DIG-labeled probes or in kit form (Table 7).
The polymerase chain reaction (PCR) has had numerous recent applications to pathogen 
detection and shrimp pathology research (Tables 5-7). In PCR, small, otherwise undetectable, 
amounts of DNA can be amplified to produce detectable quantities of the target DNA. This is 
accomplished by using specific oligonucleotide primers designed for the target DNA sequence. 
The resultant PCR product may then be compared to a known standard using gel electrophoresis, 
by reaction with a specific DNA probe of PCR products blotted directly onto a membrane or to the 
PCR products in Southern transfers. In some applications PCR products themselves may be 
labeled with DIG and used as specific DNA probes (Innis et al., 1990; Perkin Elmer, 1992). When 
DNA sequence information is known for specific nucleic acid sequences (of penaeid shrimp viruses, 
bacteria, etc.) primers can be synthesized to target specific nucleotide sequences. The unique 
target sequences may belong to a virus, a bacterium, or to any nucleic acid sequence. Various 
computer programs exist which aid in selection of optimal primers, provided target DNA sequence 
information is available (Innis et al., 1990; Perkin Elmer, 1992).
PCR has been applied to research and pathogen detection for most of the shrimp viruses 
of concern to modem day shrimp culture (Tables 5-7) (Lightner, 1999b; Nunan et al., 1998b, 2000; 
OIE, 2000b; Wang et al., 1996; Walker and Subasinghe, 1999). Other applications of PCR to shrimp 
pathology research and pathogen detection include reports of the application of PCR to the 
detection of bacterial pathogens such as the NHP bacterium (Loy et al., 1996b) and Vibrio 
penaeicida (Genmoto et al., 1996).
There is a growing need to standardize and validate the DNA-based diagnostic methods 
and the laboratories that use them (Walker and Subasinghe, 1999). Standardization of DNA-based 
diagnostic methods is almost inherent in the nature of the tests. That is, a specific DNA probe, or a 
specific set of primers, that is used to demonstrate the presence or absence of a unique DNA or RNA 
sequence does not vary from batch to batch. Hence, with proper controls, these DNA-based methods 
are readily standardized (Reddington and Lightner, 1994). However, despite the growing dependence 
of the shrimp culture industry on DNA-based diagnostic methods, none of the tests that are available 
from commercial sources nor from the literature have been validated using controlled field tests. 
Likewise, there are no formal accreditation or certification programs yet in place to assure that test 
results from technicians and laboratories running the tests are indeed accurate and properly controlled 
(Lightner and Redman, 1998; Lotz and Lightner, 1999; Lightner, 1999b). The implementation of a 
formal program by appropriate international agencies or professional societies is needed to validate
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Table 8. Viruses of Penaeid Shrimp (as of July 2001; modified from Lightner, 1996; 1999a; Lightner 
and Redman, 1998)
Family Group/Acronym/ Full Name
PARVOVIRUSES (Parvoviridae):





= spawner-isolated mortality virus
= lymphoidal parvo-like virus
BACULOVIRUSES and BACULO-LIKE VIRUSES:




 BP strains from the Gulf of Mexico, Hawaii & Eastern Pacific
= Penaeus monodon-type baculoviruses (PmSNPV type sp.): 
= MBV strains from East & SE Asia, Australia, & Indo-Pacific
= from P. japonicus in Japan
= hemocyte-infecting non-occluded baculo-like virus





= systemic ectodermal & mesodermal baculo-like virus
= rod shaped virus of P. japonicus
= penaeid acute viremia virus





= “SEEDS” (shrimp explosive epidermic disease)
= white spot baculo-like virus
= penaeid rod-shaped DNA virus
= white spot syndrome virus
= white spot virus
IRIDOVIRUS:
IRIDO = shrimp iridovirus
RNA VIRUSES
PICORNAVIRUS (Picornaviridae):
TSV = Taura syndrome virus
REOVIRUSES:
REO-III & IV = reo-like virus type II and IV
TOGA-LIKE VIRUS: 
LOVV = lymphoid organ vacuolization virus
RHABDOVIRUS:
RPS = rhabdovirus of penaeid shrimp
YELLOW HEAD VIRUS GROUP (Roniviridae, p.n.f.):
= yellow head virus of P. monodonYHV/“YBV”
GAV
LOV
= gill associated virus of P. monodon
= lymphoid organ virus of P. monodon.
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new diagnostic methods and to periodically review the accreditation and certification of diagnosticians 
and diagnostic laboratories. The establishment of regional reference laboratories for DNA-based 
diagnostic methods of penaeid shrimp/prawn pathogens would fit well into such a program with the 
goal of making these methods uniform, reliable, and readily applicable to disease control and 
management strategies for viral diseases of cultured penaeids.
SURVEY OF SHRIMP DISEASE DIAGNOSTIC LABS 
IN THE AMERICAS
The application of effective pathogen detection and disease diagnostic methods by industry 
are essential to better understand and prevent losses due to disease. Where there were only a 
handful of shrimp disease diagnostic laboratories a decade ago in the Americas, there are 40 or more 
such laboratories serving the industry today. A survey was carried out at the request of the Global 
Aquaculture Alliance to provide a snapshot of the current capabilities of a representative sample of 
laboratories in the Americas in terms of diagnostic infrastructure and the types of services provided 
(Vanpatten and Lightner, 2001). The findings of that survey are summarized here.
Laboratory characteristics
Of the approximately 40 diagnostic labs in the Americas that were contacted and requested 
to participate in this survey, 27 (~70%) of the laboratories responded. Laboratories in the United 
States, Ecuador, and Mexico comprise 63% of the diagnostic laboratories that were surveyed. 
Colombia, Panama, Brazil, Guatemala, Nicaragua, Honduras, and Costa Rica comprise the other 
30% of the participating diagnostic laboratories. Nearly half (41%) of the diagnostic laboratories 
are associated with a university or research institution that provides services to the shrimp farming 
industry by cost recovery. Private, for-profit commercial laboratories (~19%) that provide service 
to the shrimp farming industry, and farm-owned laboratories (~26%) that are part of a shrimp 
farming company to which it provides almost exclusive services together comprise ~45% of the 
laboratories. Government-funded laboratories that serve a particular country’s shrimp farming 
industry comprise 15% of the laboratories. Half of the laboratories responding employ less than 5 
staff members (52%) while 41% employ between 6 to 10 staff members. Two laboratories employ 
more than 10 staff (7%).
Tests provided
The approximate number of diagnostic assays (using histological, microbiological, or 
molecular methods) ranged from less than 100 (7%) to greater than 10,000 (11%), with the category 
of 100 to 500 assays accounting for 30% of the total responses for the year 2000. Some 82% of the 
laboratories surveyed performed histology. Routine histology using paraffin-embedded tissues 
was employed by 74% of the laboratories and special stains (i.e. Feulgen for DNA, Giemsa for 
parasites, Steiner & Steiner for intracellular bacteria, etc.) were used by 60% of the laboratories. 
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Routine microbiology services are offered by 78% of the laboratories with routine isolation 
and identification of bacteria being offered by 63% of the laboratories. Methods used for bacterial 
identification include, classical tube methods (82%), API NFT, API 20E, or other API system (88%), 
the Biolog system (18%), and others such as BBL Crystal, NF/E, VITEK, and molecular methods 
(35%). Kirby-Bauer antibiotic sensitivity testing with commercially available disks and in-media 
antibiotic inhibitory concentration (MIC) assays accounted for 59% and 48% of the responses, 
respectively. Only 22% of the laboratories provide fungal isolation and identification services. 
None of the surveyed laboratories use shrimp primary cell cultures or insect and fish cell lines for 
shrimp virus isolation and culture.
Antibody-based (serological) techniques are used by 48% of the laboratories, with these labs 
performing techniques such as immunohistochemistry (40%) and ELISA tests (22%). Roughly a third 
of the laboratories responding use immunohistochemistry for testing histological sections for WSSV 
(37%), and TSV (33%). Only one laboratory indicated that they offer an antibody-based test for YHV. Of 
the 13 respondents that provide antibody-based tests, 11 purchase the antibodies they use from a 
commercial supplier (DiagXotics, Inc.), while one responded that the antibodies were made “in house.” 
Molecular methods (i.e. dot blots and in situ hybridization assays with gene probes, and 
PCR/RT-PCR) were the diagnostic methods used most frequently by the survey respondents 
(93%). Gene probes run as dot blots on membranes were used by 59% of the laboratories and are 
most frequently applied to tests for WSSV (59%), IHHNV(52%), NHP(41%), and HPV (19%). Gene 
probes used with in situ hybridization (ISH) with paraffin embedded histological sections were 
performed by 82% of the labs and are most frequently used for WSSV (74%), TSV (70%), IHHNV 
(56%), YHV (48%), NHP(41%), and HPV (24%). The gene probes used for the above procedures 
are generally purchased from a commercial supplier (82%), while only 15% of the respondents 
reported that they make the probes “in house.”
Most of the laboratories contacted (74%) use gene amplification (PCR & RT-PCR) methods. 
The respondents indicated that they use PCR/RT-PCR to assay for WSSV (74%), YHV (48%), 
IHHNV (48%), TSV (44%), NHP (22%), HPV (15%), BP, MBV, rickettsia, and Vibrio spp. (11%). The 
survey indicated that most (19 of 27) of the labs purchase the oligonucleotide primers they use for 
PCR/RT-PCR from commercial sources. Primers for WSSV, TSV, IHHNV, and YHV are most frequently 
purchased by these laboratories, while only a few labs purchase primers for HPV, NHP, and other 
agents such as BP, MBV, rickettsia, and Vibrio spp., and primers for use as an internal control (e.g. 
for shrimp ribosomal DNA). In the Americas, PCR/RT-PCR kits are most often purchased from 
DiagXotics (59%), IQ-2000 (30%), and others such as Concepto Azul, Corpo Gen., and Karson Inc. 
(15%). The kits are most frequently used for WSSV (59%), YHV (41%), TSV (37%), IHHNV (30%), 
HPV (11%), and NHP (11%). The ISH kits are purchased primarily from DiagXotics (70%), and IQ- 
2000 (4%). The ISH are most frequently used for TSV (67%), WSSV (67%), IHHNV (44%), YHV 
(44%), NHP (33%), and HPV (11%).
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BIOSECURITY IN PENAEID SHRIMP AQUACULTURE
“Biosecurity” has become a commonly used term in the shrimp culture industries of the 
Americas only in the past few years. However, the concept that it represents is, and has been, the 
foundation of nearly all mature and successful food animal producing industries for decades. 
Many producers of cattle, swine, poultry, and many aquatic species (e.g. trout, salmon, and catfish) 
rely on the principles of biosecurity for sustainable production (Bullis and Pruder 1999). Biosecurity, 
as it is being applied to shrimp aquaculture may be defined as the practice of exclusion of specific 
pathogens from cultured aquatic stocks in broodstock facilities, hatcheries, and farms, or from 
entire regions or countries for the purpose of disease prevention. Although the term “disease- 
free” is commonly used by marketers to describe the live shrimp products in commerce, in reality no 
truly “disease-free” shrimp (or any other for that matter) exist in natural or farm environments. 
In the wake of the epizootics due principally to the shrimp viruses TSV and WSSV that 
swept through the main penaeid shrimp growing regions in the Americas, the shrimp farming 
industry now seems intent to utilize any of the applicable concepts of biosecurity in its farms. The 
application of biosecurity concepts to many of the existing types of shrimp farming, as they have 
been applied to poultry for example, is not something that can be accomplished easily or in short 
term. The industry has thousands of hectares of farms and hundreds of hatcheries (Rosenberry, 
2001), few of which were designed to afford managers with much of an opportunity to totally 
prevent particular pathogens from being introduced and becoming established or to exclude them 
during normal farming activities. Nonetheless, biosecurity is a broad concept and much can be 
done to reduce losses due to particular pathogens by utilizing “seed stocks” that are free of the 
major pathogens of concern and by modifying existing farms and their management routines in 
order to apply biosecure concepts. Furthermore, the application of biosecurity concepts to shrimp 
aquaculture, will contribute significantly to making the industry much more sustainable and 
environmentally responsible well into the future.
Key to any effort at excluding pathogens are the following principles and tools: 
1. Knowledge of diseases of concern.
2. Availability of adequate diagnostic and detection methods and services for
the pathogens of concern.
3. A list of excludable diseases/pathogens of concern.
4. Control of the shrimp stocks that are farmed.
5. Adequate environmental control to prevent the introduction of pathogens of concern.
6. The use of effective management practices that ensure continuous implementation
of pathogen exclusion methods and that policies are in place and practiced.
7. Disinfection and pathogen eradication plans in place to contain and eradicate disease
outbreaks due to pathogens of concern.
Adequate Diagnostic and Detection Methods
The application of biosecurity by any component of the penaeid shrimp culture industry 
(i.e. a facility, a geographic region, or a country) is dependent upon the availability of sensitive, 
18 Disease Control in Fish and Shrimp Aquaculture
accurate, cost effective disease diagnosis and pathogen detection methods. Those that are available 
from the literature, commercially in the form of kits, or from public or private diagnostic laboratories 
(discussed previously in this review). Highly sophisticated methods for pathogen detection in 
various sorts of samples are of little value to the shrimp farming industry if those methods exist 
only in the laboratories that developed them, but they are not readily available to an industry that 
could benefit from their application and use. Likewise, of little value to biosecurity programs are 
other diagnostic and pathogen detection methods which that may be generally available, but 
which are not sufficiently sensitive or accurate to meet the industry’s requirements. Various 
manuals can serve as guides as to the available methods for disease screening and diagnosis. The 
OIE Diagnostic Manual for Aquatic Animal Diseases (OIE, 2000b) provides methods that have 
national or international approval for disease screening and diagnosis. Tables 5-6 list the OIE 
notifiable and listed shrimp viruses and the available diagnostic and detection methods for each. 
List of Excludable Diseases/Pathogens of Concern
An important aspect of biosecurity is defining what specific diseases/pathogens or types 
of pathogens are to be excluded. Not all potential causes of disease in shrimp aquaculture can be 
excluded by the application of a biosecurity program. Shrimp have as part of their natural microbial 
flora and in their aquatic environment, a large and diverse population of microorganisms, some of 
which are facultative pathogens ready to strike when the shrimp become compromised by any 
number of stressors. Certain Vibrio spp. provide a good example of a group of organisms that live 
in the shrimp’s environment often as part of their normal microflora inhabiting the surface of their 
cuticle or colonizing areas of the gut or hepatopancreas (Brock and Lightner, 1990; Fulks and Main, 
1992). Some Vibrio spp. can become deadly pathogens in “stressed” shrimp. Hence, diseases due 
to “abiotic” agents (i.e. “stress”, toxicants, environmental extremes, nutritional imbalances, etc.) or 
those due to opportunistic “biotic” agents that are either commonly present in the culture 
environment or part of the shrimp’s normal microflora, are not excludable and, therefore, should not 
be among the listed disease agents to be excluded in a biosecurity plan. However, the management 
of such diseases through farm design, the use of appropriate feeds and feed application, and the 
quality of overall management are nonetheless essential components of successful shrimp farming. 
What should be on a list of pathogens in a biosecurity program? Because not all potential 
causes of disease can be excluded, the development of a list of specific pathogens to be excluded 
is among the essential elements of an aquaculture biosecurity plan, whether it be for a single 
culture facility, a group of farms, a country, or an region made of several countries. However, for a 
list of excludable diseases/pathogens to be meaningful, certain criteria must be met. Basic information 
on the biology of the pathogen must be known. For example, for each listed pathogen, at least 
some of the key information on the host range, approximate geographic distribution, and means of 
transmission should be known. Generally, the disease agents listed in a biosecurity plan should be 
agents that: 1) are infectious and, usually, obligate pathogens; 2) are not ubiquitous or part of the 
shrimps’ normal flora; 3) have a limited geographic and/or host range; 4) may cause economically 
significant losses (i.e. high mortality or poor culture performance); and 5) cause a disease that 
cannot be readily managed (i.e. by the use of antibiotics, disinfectants, etc.).
Examples of specific lists of excludable pathogens are available and may be helpful if 
referred to when formulating a pathogen list for a facility, a particular region, or a country. The U.S. 
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Marine Shrimp Farming Consortium’s (USMSFC) publishes a list of pathogens (Table 9) that it 
strives to exclude from its facilities and lines of domesticated shrimp in its annual publications 
(Bullis, 2001). Also indicated in Table 9 are those disease agents listed by the OIE (2000a, 2000b) 
as “notifiable” (one asterisk) and “other significant pathogens” (two asterisks). The OIE maintains 
at its web site (www.oie.org) and publishes regularly an International Aquatic Animal Health Code 
and Diagnostic Manual. The OIE currently has nine crustacean diseases (eight of which are 
penaeid virus diseases) on its list of pathogens which pose a threat to international commerce, 
fisheries, and aquaculture of crustaceans (especially shrimp) (Table 10). Before a disease may be 
included in the OIE lists of notifiable and listed diseases, OIE has set criteria that must be met: 1) the 
etiological agent must be known, 2) reliable diagnostic(s) methods must be available, and 3) the 
disease must be a significant disease of local, regional, or international importance. The OIE 
criteria for listing are very similar to those used by the USMSFC. Pathogen lists, such as the OIE 
list, are useful models for setting up a biosecurity program that is based on exclusion of a list of 
specific pathogens and the diagnostic methods for surveillance and diagnosis.
While biosecurity has as its goal the exclusion of known pathogens for which 
epizootiological data is available and for which there are adequate diagnostic and detection methods, 
the application of biosecure practices can also reduce the likelihood of the introduction of an 
unknown or poorly understood pathogen. However, to be most effective, the epizootiology of a 
pathogen (i.e. its hosts, biology, and methods of transmission) that is the etiological agent of a 
particular disease must be sufficiently known to permit managers to understand how the pathogen 
is transmitted and how to prevent its entry and spread. It is impractical, if not impossible, to expect 
biosecurity to lead to the development of “disease free” or “pathogen-free” shrimp stocks. It is 
equally impractical to expect to farm such stocks in an environment where every potential pathogen 
is excluded.
Control of Shrimp Stocks
Perhaps the single most important principle of biosecurity is stock control. Ironically, 
most of the world’s penaeid shrimp farming industry depends on the capture of wild postlarvae or 
broodstock to provide the “seed stock” used to stock farms (Argue and Warren, 1999). Introduction 
of diseases (pathogens) with infected live shrimp for aquaculture to new locations (i.e. to broodstock 
facilities, hatcheries, farms, groups of farms, countries, or geographic regions) was identified by 
recent risk assessments done in the United States (EPA, 1999) and Australia (AQUIS, 2000) as 
among the most likely routes by which non-indigenous shrimp viruses might be introduced. Other 
routes by which shrimp pathogens might be introduced to new regions were also identified in 
these risk assessments, including some of the routes that are ranked on a semi-log scale in Figure 
1 according to their relative risk (in the author’s opinion).
While some application of biosecurity principles are possible with an industry that uses 
wild stocks for seed production, consistency in preventing disease and pathogen introduction is 
problematic because of a variety of problems inherent in having laboratory testing performed. 
Such problems may include limitations to the accuracy and sensitivity of the test(s) used , 
representative sampling and sample sizes needed for statistical confidence, and problems with 
getting the required samples to diagnostic laboratories, tested, and reported within what is often a 
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Table 9. U.S. Marine Shrimp Farming Consortium (USMSFC) year 2001 working list of “specific” and 
excludable pathogens of American penaeids and Asian penaeids (from Bullis, 2001)
Pathogen Type Pathogen/Pathogen Group Pathogen 
Category2
Viruses * WSSV - the white spot syndrome viruses
(Nimaviridae, proposed new family) C-1
* YHV, GAV, LOV - the Oka viruses 
(Roniviridae, proposed new family) C-1
* TSV - a picornavirus C-1
** BPV1 - an occluded enteric baculovirus C-2
** MBV1 - an occluded enteric baculovirus C-2
** BMN1 - a non-occluded enteric baculo-like virus C-2
** IHHNV - a systemic parvovirus C-1
** SMV - an enteric parvovirus C-1
HPV - enteric parvoviruses C-2
Procaryotes




* OIE notifiable pathogen as of May 1999.
** OIE listed pathogen as of May 1999 (OIE, 2000a; 2000b).
1 The 1995 Committee report on virus taxonomy (Murphy et al., 1995) removed crustacean baculoviruses 
from the Baculoviridae and assigned them to a position of unknown taxonomic position. The viruses, BP, 
MBV, and BMN are likely to remain in the Baculoviridae, while the WSSV-group is not related to the 
Baculoviridae, and it has now been proposed to represent a new family, the Nimaviridae.
2 Pathogen category (modified from Lotz et al., 1995) with C-1 pathogens defined as excludable pathogens 
that can potentially cause catastrophic losses in one or more American penaeid species; category 2 pathogens 
are serious, potentially excludable; and category 3 pathogens have minimal effects, but may be excluded from 
breeding centers, hatcheries, and some types of farms.
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Table 10. OIE notifiable and listed penaeid shrimp diseases and their current, presently known 
distribution in wild and cultured stocks (modified from Lightner, 1996; Lightner and Redman, 
1998; OIE, 2000b)
Virus or Virus Group Eastern Hemisphere Western Hemisphere
OIE Notifiable Viruses of Penaeid Shrimp:
WSSV wild & cultured wild & cultured 
reported, but not 
confirmed (false 
positives were reported)
YHV/GAV-group wild & cultured
TSV cultured wild & cultured
OIE Listed Viruses of Penaeid Shrimp:
IHHNV wild & cultured wild & cultured
BP not reported wild & cultured
MBV wild & cultured reported; not enzootic
BMN wild & cultured not reported
SMV cultured not reported
relatively short period of time between the time the wild seed stock is collected or spawned and the 
time by which transport and/or stocking must occur. Furthermore, the prevalence and severity of 
infection of significant pathogens in wild populations may be quite low, making their detection a 
difficult task. These factors lead frequently to false negative results when wild stocks (nauplii, 
larvae, PLs or broodstock) are sampled and screened using even the most sensitive molecular 
methods available. Hence, while more sensitive and accurate diagnostic tests are becoming available 
each year, no test is likely to ever be 100% accurate (OIE, 2000b). The best way to be sure of the 
pathogen status of any given shrimp stock is have control of the stock and to monitor it for specific 
pathogens over time, thus building a documented history of the particular stock as being free of 
specific pathogens. This is the concept of programs that develop domesticated lines of specific 
pathogen-free stocks.
Disease management through exclusion of specific pathogens is commonplace in modem 
agriculture. This concept of developing stocks that are specific pathogen free (SPF) and rearing of 
these stocks in regions where the specific pathogens of concern are excluded has been used in the 
Western Hemisphere with mixed success. The successful application of the SPF concept is, of 
course, dependent upon the absence of the pathogen(s) of concern in the stocks being reared (or 
that are present), on the availability of sensitive and accurate detection and diagnostic methods for 
the pathogen(s), and the presence of an effective barrier (i.e. facility design and geographic location, 
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government mandated import restrictions, etc.) to prevent the introduction of the specific pathogen(s) 
intended to be excluded. In situations where specific pathogens may not be excludable, the 
development and use of specific pathogen-resistant or SPR stocks may provide a valuable alternative 
to using exclusively SPF stocks.
In the Western Hemisphere, SPF stocks of P. stylirostris and P. vannamei have been 
developed and these are being cultured successfully in some locations (Wyban, 1992; Wyban et 
al., 1992; Carr et al., 1994; Pruder et al., 1995). The ICES Guidelines (Table 11; Sindermann, 1990) 
were followed for the development of these stocks. The determination of which specific pathogens 
the selected stocks were to be free of was based on a working list of specific, excludable pathogens 
(Wyban, 1992; Lotz et al., 1995). The most current working list for the U.S. Marine Shrimp Farming 
Consortium (USMSFC) includes eight viruses (WSSV, the YHV/GAV-group, TSV, IHHNV, HPV, BP, 
MB V, and BMN), the rickettsia-like bacterium that causes necrotizing hepatopancreatitis (NHP), 
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Figure 1.  The relative risk presented by certain types of shrimp products,
ranging from live shrimp for aquaculture, frozen shrimp for 
reprocessing and marketing, to processed feeds that contain shrimp 
meals, to the shrimp farming industry in a geographic region, a 
country, or a region within a country, or individual farm or hatchery
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Table 11. Recommended steps in the ICES guidelines for risk reduction in aquatic species 
introductions (modified from Sindermann and Lightner, 1988)
Original ICES Guidelines Adapted to SPF shrimp development
1. Conduct comprehensive disease study 
in native habitat
1. Identify stock of interest (i.e. cultured or wild)
2. Evaluate stock’s health/disease history
2. Transfer {founder stock} system in 
recipient area
3. Acquire and test samples for specific listed 
pathogens (SLPs) and pests
3. Maintain and study closed system population. 4. Import and quarantine founder (F0) population;
monitor F0 stock4. Develop broodstock in closed system
5. Grow isolated F individuals; destroy
original introductions
5. Produce F1 generation from F0 stock
6. Culture F1 stock through critical stage(s); 
monitor general health and test for SLPs6. Introduce small lots to natural waters -
continue disease study 7. If SLPs, pests, other significant pathologies 
are not detected, F-1 stock may be defined as
SPF and released from quarantine
SPF stocks developed by the USMSFC were developed in the spirit of the ICES Guidelines 
(Table 11; Figure 2). To begin the process, each “SPF candidate population” of wild or cultured 
shrimp stocks of interest was identified. Samples of the stock were taken and tested using 
appropriate diagnostic and pathogen detection methods for the specific pathogens of concern. If 
none were found, a founder population (F0) of the “candidate SPF” stock was acquired and reared 
in primary quarantine. During primary quarantine, the F0 stock was monitored for signs of disease, 
sampled, and tested periodically for specific pathogens. If any pathogens of concern were detected, 
the stock was destroyed. Those stocks that tested negative for pathogens of concern through 
primary quarantine (which ran from 30 days to as much as 1 year for some stocks) were moved to 
a separate secondary quarantine facility for maturation, selection, mating, and production of a 
second (F1) generation. The F1 stocks were maintained in quarantine for further testing for specific 
pathogens of concern. Those that tested negative were designated as SPF and used to produce 
domesticated lines of SPF and “high health” (Wyban et al., 1992; Pruder et al., 1995). The SPF and 
high health stocks of P. vannamei were used successfully in U.S. shrimp farms in 1993, 1994, and 
since 1997 resulted in more than double the production per crop that had been previously obtained 
at the same farms in previous years when the farms cultured non selected lines of P. vannamei, 
which in previous crops, had been persistently affected by “runt deformity syndrome” (RDS) due 
to chronic infection by IHHNV, or affected by TSV and WSSV (Brock and Main, 1994; Pruder et al., 
1995; Lightner, 1996a, 1996b; Bullis and Pruder 1999).
Stock control is a critical component of biosecurity. As long as the industry in the 
Americas remains dependent on wild stocks, it cannot expect to be consistently successful in 
excluding pathogens of concern in the wild seed stocks that it relies on. The use of wild broodstock, 
and especially wild postlarvae, leaves the farms that rely on this source of seed stock particularly 
vulnerable to the introduction of pathogens of concern. While numerous methods have been 
incorporated into the operational design and management of shrimp farms previously affected by 
TSV and WSSV to eradicate them and to insure that they are not reintroduced, none can be 
expected to provide much protection against crop losses in farms that use seed stock derived from 
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Figure 2. Schematic diagram of the steps followed by the U.S. Marine Shrimp Farming 
Consortium (USMSFC) in developing specific pathogen-free (SPF) breeding lines 
wild stock sources. The use of only domesticated shrimp stocks that have a known history of 
being free of pathogens of concern can help to mitigate this risk. However, a SPF history comes 
only from a long-term captive breeding and disease surveillance program at a facility that has a 
fully functional and effective biosecurity plan.
ENVIRONMENTAL CONTROL AND BEST 
MANAGEMENT PRACTICES
A variety of environmental and best management practice strategies have been attempted 
for the control of viral diseases in penaeid shrimp aquaculture. These strategies range from the use 
of improved culture practices (i.e. where sources of virus contamination are reduced or eliminated, 
source water is treated, filtered, and aged to remove potential vectors, culture ponds fallowed and 
treated between crops, routine sanitation practices are improved, stocking densities are reduced, 
etc.) to stocking “specific pathogen-free” (SPF) or “specific pathogen resistant” (SPR) species or 
stocks. Because these topics are beyond the scope of the present review, the author refers the 
reader to other papers in which this topic has been thoroughly reviewed (Bullis and Pruder, 1999; 
Lee, in press; Takashima et al., 2001).
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